Table 3 Surgery related information
Characteristic | ACE-27 low (0–1) | ACE-27 high (2–3) | p value |
|---|---|---|---|
n = 132 | n = 32 | ||
Age (median (IQR)) | 68 (66,70) | 67 (66,71) | 0.534 |
Type of surgery | |||
 PDS n(%) | 100 (75.75) | 25 (78.12) | 0.778 |
 NACT/IDS n(%) | 31 (23.48) | 7 (21.87) |  |
SCS | Â | Â | Â |
  ≤ 3 n(%) | 94 (71.21) | 25 (78.12) | 0.284 |
  ≥ 4 n(%) | 33 (25.00) | 5 (15.62) |  |
 Operation time (median (IQR)) | 4.6 (3.5,5.3) | 3.8 (2.7,4.8) | 0.016 |
ASA | |||
 I–II n(%) | 97 (73.48) | 20 (62.5) | 0.218 |
 III–IV n(%) | 35 (26.51) | 12 (37.5) |  |
Residual disease | Â | Â | Â |
 R0 n(%) | 81 (61.36) | 17 (53.12) | 0.41* |
 R1 n(%) | 29 (21.96) | 8 (25.00) |  |
 R2 n(%) | 9 (6.82) | 4 (12.50) |  |
Ascites | Â | Â | Â |
  < 1000 mL | 66 (50.00) | 11 (34.38) | 0.033 |
  ≥ 1000 mL | 44 (33.33) | 18 (56.25) |  |
 Unintended ICU admission | 12 (9.09) | 8 (25.00) | 0.014 |
Perioperative complication | |||
 II–V n(%) | 39 (29.54) | 15 (46.87) | 0.061 |
 III–V n(%) | 9 (6.82) | 7 (21.87) | 0.018* |
 Grade III + complication or unintended ICU admission n(%) | 16 (12.12) | 11 (34.37) | 0.002 |
Intraoperative blood loss | |||
  ≤ 0.5L n(%) | 66 (50.00) | 20 (62.50) | 0.442 |
 0.5 ~ 1L n(%) | 40 (30.30) | 7 (21.87) |  |
  ≥ 1L n(%) | 26 (19.69) | 5 (15.62) |  |
 Days to chemotherapy (median (IQR)) | 11 (9,19) | 10 (9,27) | 0.692 |
Cycle of chemotherapy | |||
 No chemotherapy | 15 (11.36) | 5 (15.62) | 0.747* |
  < 6 cycles n(%) | 56 (42.42) | 12 (37.5) |  |
  ≥ 6 cycles n(%) | 60 (45.45) | 13 (40.62) |  |
 LOS (median (IQR)) | 20 (17,25) | 19 (15,22) | 0.323 |